Research
Adherence
Semaglutide treatment significantly reduces emotional and uncontrolled eating scores in patients with hypothalamic obesity, leading to improved quality of life and social functioning.
Semaglutide not only helps with weight loss but also significantly reduces emotional and uncontrolled eating, leading to improved quality of life and social functioning. Patients report feeling more confident and less isolated.
ModerateSupportsMEDIUM confidence
Emotional and uncontrolled eating scores (range: 0–100) decreased by 44 (95% CI: − 69 to − 19, p = 0.011) and 27 units (95% CI: − 63 to 9, p = 0.097), respectively. Interviews revealed reduced hunger, improved self-confidence, less isolation, and higher productivity.
Why this rating
Small case series, but includes qualitative interviews and validated questionnaires.
Source
Semaglutide treatment in hypothalamic obesity: Two-Year outcomes on body composition, appetite, and quality of life
Erlend Gjersdal et al. · Pituitary · 2025
DOI 10.1007/s11102-025-01564-7
case_series · n=4Cited 5×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Adherence
- Regular physical activity (at least 150 minutes/week of moderate-intensity) reduces all-cause and cardiovascular mortality by 20-30% and lowers the risk of type 2 diabetes by 25-35%.Strong
- Increasing physical activity from a sedentary lifestyle to an active one in middle adulthood significantly reduces the risk of coronary events compared to remaining sedentary.Strong
- Resistance exercise is the only intervention capable of consistently restoring muscle function and strength in sarcopenia, partially overcoming age-related anabolic resistance.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →